REGN – Bullish Engulfing + RSI Divergence at Weekly DemandRegeneron (REGN) is showing strong technical signals of potential reversal from a key weekly demand zone, replicating a setup similar to March 2021.
🔹 Bullish Engulfing Candle forms directly at the demand zone after a multi-month downtrend.
🔹 Volume Spike confirms strong buyer interest.
🔹 RSI shows
Key facts today
On January 7, 2025, shareholders sued Regeneron Pharmaceuticals for misrepresenting pricing and financial performance of Eylea, following DOJ accusations of inflated Medicare reimbursements.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
855.53 MXN
92.00 B MXN
296.10 B MXN
104.06 M
About Regeneron Pharmaceuticals, Inc.
Sector
Industry
CEO
Leonard S. Schleifer
Website
Headquarters
Tarrytown
Founded
1988
FIGI
BBG00JX0QK71
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.
Regeneron Pharmaceutical's MFI implying "Trough in the making"1/ Using just this indicator " Alon" is a very dangerous game like you can blow up your
account !!!
2/Non the less, such readings accompanied by (-86%) or ( 78-%) or (-91%) draw downs
such as on the chart above has resulted in the past, in 3 occasions, in big and historical
bullish moves !!! "Gener
Regeneron Pharmaceuticals | REGN | Long at $502.28Regeneron Pharmaceuticals NASDAQ:REGN stock dropped more than 17% today due to mixed Phase 3 trial results for itepekimab, a potential COPD drug. However, the company has an extensive drug pipeline, raked in over $14 billion last year, and is currently trading at a price-to-earnings of 15x. Debt-t
Regeneron Pharmaceuticals Q2-Q3 Confirmed "Troughing in ProgressIF we do not crash like many Elliottsions are suggesting implying of Grand 5th wave since 1929...
iF we do not start WW3...
IF everything utterly absolute out there in the pharmaceutical industries locally
and globally...
IF our studies of the relation between XLV and Regeneron Pharmaceuticals is
r
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
REGN5027988
Regeneron Pharmaceuticals, Inc. 2.8% 15-SEP-2050Yield to maturity
7.70%
Maturity date
Sep 15, 2050
REGN5027987
Regeneron Pharmaceuticals, Inc. 1.75% 15-SEP-2030Yield to maturity
5.33%
Maturity date
Sep 15, 2030
See all REGN bonds
Curated watchlists where REGN is featured.
Related stocks
Frequently Asked Questions
The current price of REGN is 9,815.00 MXN — it has increased by 3.45% in the past 24 hours. Watch REGENERON PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange REGENERON PHARMACEUTICALS INC stocks are traded under the ticker REGN.
REGN stock has risen by 3.27% compared to the previous week, the month change is a −17.19% fall, over the last year REGENERON PHARMACEUTICALS INC has showed a −43.75% decrease.
We've gathered analysts' opinions on REGENERON PHARMACEUTICALS INC future price: according to them, REGN price has a max estimate of 17,908.17 MXN and a min estimate of 9,601.83 MXN. Watch REGN chart and read a more detailed REGENERON PHARMACEUTICALS INC stock forecast: see what analysts think of REGENERON PHARMACEUTICALS INC and suggest that you do with its stocks.
REGN stock is 4.01% volatile and has beta coefficient of 0.75. Track REGENERON PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is REGENERON PHARMACEUTICALS INC there?
Today REGENERON PHARMACEUTICALS INC has the market capitalization of 1.06 T, it has increased by 3.28% over the last week.
Yes, you can track REGENERON PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
REGENERON PHARMACEUTICALS INC is going to release the next earnings report on Jul 31, 2025. Keep track of upcoming events with our Earnings Calendar.
REGN earnings for the last quarter are 168.40 MXN per share, whereas the estimation was 176.63 MXN resulting in a −4.66% surprise. The estimated earnings for the next quarter are 163.26 MXN per share. See more details about REGENERON PHARMACEUTICALS INC earnings.
REGENERON PHARMACEUTICALS INC revenue for the last quarter amounts to 62.06 B MXN, despite the estimated figure of 66.54 B MXN. In the next quarter, revenue is expected to reach 62.73 B MXN.
REGN net income for the last quarter is 16.57 B MXN, while the quarter before that showed 19.13 B MXN of net income which accounts for −13.41% change. Track more REGENERON PHARMACEUTICALS INC financial stats to get the full picture.
Yes, REGN dividends are paid quarterly. The last dividend per share was 16.96 MXN. As of today, Dividend Yield (TTM)% is 0.34%. Tracking REGENERON PHARMACEUTICALS INC dividends might help you take more informed decisions.
REGENERON PHARMACEUTICALS INC dividend yield was 0.00% in 2024, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jun 11, 2025, the company has 15.11 K employees. See our rating of the largest employees — is REGENERON PHARMACEUTICALS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. REGENERON PHARMACEUTICALS INC EBITDA is 91.28 B MXN, and current EBITDA margin is 32.79%. See more stats in REGENERON PHARMACEUTICALS INC financial statements.
Like other stocks, REGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade REGENERON PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So REGENERON PHARMACEUTICALS INC technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating REGENERON PHARMACEUTICALS INC stock shows the sell signal. See more of REGENERON PHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.